Clinical Trial

Intravenous Lidocaine Infusion Reduce Postoperative Pulmonary Complications in Patients Undergoing Minimally Invasive Esophagectomy

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 22, 2024 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this double-center, double-blind, randomized controlled clinical trial is to compare the effect of intravenous lidocaine infusion on postoperative pulmonary complications in patients undergoing minimally invasive esophagectomy. The main question it aims to answer are whether intravenous lidocaine reduce postoperative pulmonary complications in patients undergoing minimally invasive esophagectomy. Participants will be given intravenous lidocaine infusion in lidocaine group or placebo in control group.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-11-13.
Trial Details
NCT Number NCT06138041
Lead Sponsor Sichuan Cancer Hospital and Research Institute
Conditions Postoperative Pneumonia, Postoperative Pulmonary Atelectasis, Postoperative Pulmonary Edema
Enrollment 770 participants
Start Date 2025-02-01
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-08-30 (estimated)
Updated on ClinicalTrials.gov 2024-10-22